Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Denali Therapeutics is a US biopharmaceutical company dedicated to developing brain-penetrant therapies for neurodegenerative diseases. The company focuses on the research and development of medicines to stop the progression of Alzheimer's, Parkinson's, ALS, and other severe brain disorders.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Denali Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Denali Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.68 USD.
Across its last 3 earnings reports, Denali Therapeutics stock moved by ±0.7% on average the following day. The largest reaction was -1.1% on 02/26/2026; 0 of 3 reactions were positive.
Denali Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.